402 related articles for article (PubMed ID: 22444998)
1. Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer.
Chen AM; Hall WH; Li J; Beckett L; Farwell DG; Lau DH; Purdy JA
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):165-9. PubMed ID: 22444998
[TBL] [Abstract][Full Text] [Related]
2. Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol.
Chen AM; Wang PC; Daly ME; Cui J; Hall WH; Vijayakumar S; Phillips TL; Farwell DG; Purdy JA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):771-7. PubMed ID: 24606846
[TBL] [Abstract][Full Text] [Related]
3. Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.
Thomas TO; Refaat T; Choi M; Bacchus I; Sachdev S; Rademaker AW; Sathiaseelan V; Karagianis A; Mittal BB
Radiat Oncol; 2015 Apr; 10():94. PubMed ID: 25927572
[TBL] [Abstract][Full Text] [Related]
4. Tolerance of the Brachial Plexus to High-Dose Reirradiation.
Chen AM; Yoshizaki T; Velez MA; Mikaeilian AG; Hsu S; Cao M
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):83-90. PubMed ID: 28587056
[TBL] [Abstract][Full Text] [Related]
5. Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications.
Eblan MJ; Corradetti MN; Lukens JN; Xanthopoulos E; Mitra N; Christodouleas JP; Grover S; Fernandes AT; Langer CJ; Evans TL; Stevenson J; Rengan R; Apisarnthanarax S
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):175-81. PubMed ID: 22658442
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer.
Hall WH; Guiou M; Lee NY; Dublin A; Narayan S; Vijayakumar S; Purdy JA; Chen AM
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1362-7. PubMed ID: 18448267
[TBL] [Abstract][Full Text] [Related]
7. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy.
Wu SG; Huang SJ; Zhou J; Sun JY; Guo H; Li FY; Lin Q; Lin HX; He ZY
Radiat Oncol; 2014 Dec; 9():292. PubMed ID: 25499205
[TBL] [Abstract][Full Text] [Related]
9. Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer.
Yi SK; Hall WH; Mathai M; Dublin AB; Gupta V; Purdy JA; Chen AM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1060-4. PubMed ID: 21536393
[TBL] [Abstract][Full Text] [Related]
10. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.
Forquer JA; Fakiris AJ; Timmerman RD; Lo SS; Perkins SM; McGarry RC; Johnstone PA
Radiother Oncol; 2009 Dec; 93(3):408-13. PubMed ID: 19454366
[TBL] [Abstract][Full Text] [Related]
11. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
14. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
15. [Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus].
Boisselier P; Racadot S; Thariat J; Graff P; Pointreau Y
Cancer Radiother; 2016 Oct; 20(6-7):459-66. PubMed ID: 27614529
[TBL] [Abstract][Full Text] [Related]
16. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersäll P
Acta Oncol; 2019 Aug; 58(8):1178-1186. PubMed ID: 31066326
[No Abstract] [Full Text] [Related]
18. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
19. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
